| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.989 | 0.003 | 0.989 | Cyclophilin D inhibitor | 0.984 0.003 CID_154699826 | ||
| 0.965 | 0.003 | 0.965 | Lipoxygenase inhibitor | 0.401 0.037 CID_154699826 | ||
| 0.942 | 0.001 | 0.942 | Insulin sensitizer | 0.896 0.002 CID_154699826 | ||
| 0.927 | 0.003 | 0.927 | Hypoglycemic | 0.923 0.003 CID_154699826 | ||
| 0.9 | 0 | 0.9 | Thiazolidinedione | 0.386 0 CID_154699826 | ||
| 0.852 | 0.004 | 0.858 | Antioxidant | 0.858 0.004 CID_154699826 | CID_154699826 | |
| 0.841 | 0.001 | 0.841 | Lipid peroxidase inhibitor | 0.787 0.002 CID_154699826 | ||
| 0.785 | 0.004 | 0.785 | Hypolipemic | 0.737 0.004 CID_154699826 | ||
| 0.737 | 0.003 | 0.737 | NOS3 expression enhancer | 0.717 0.003 CID_154699826 | ||
| 0.655 | 0.003 | 0.655 | Peroxisome proliferator-activated receptor gamma agonist | 0.486 0.004 CID_154699826 | ||
| 0.579 | 0.01 | 0.631 | Free radical scavenger | 0.631 0.007 CID_154699826 | CID_154699826 | |
| 0.569 | 0.002 | 0.569 | Peroxisome proliferator-activated receptor gamma antagonist | 0.169 0.005 CID_154699826 | ||
| 0.555 | 0.004 | 0.578 | Insulin secretagoues | 0.578 0.004 CID_154699826 | CID_154699826 | |
| 0.515 | 0.003 | 0.515 | Aldose reductase inhibitor | 0.447 0.004 CID_154699826 | ||
| 0.566 | 0.063 | 0.721 | Antiinflammatory | 0.721 0.027 CID_154699826 | CID_154699826 | |
| 0.525 | 0.032 | 0.525 | Antiobesity | 0.521 0.033 CID_154699826 | ||
| 0.48 | 0.004 | 0.48 | ABCA1 expression enhancer | 0.273 0.005 CID_154699826 | ||
| 0.456 | 0.007 | 0.456 | Sodium/bile acid cotransporter inhibitor | 0.42 0.012 CID_154699826 | ||
| 0.431 | 0.018 | 0.466 | Vasodilator | 0.466 0.015 CID_154699826 | CID_154699826 | |
| 0.396 | 0.002 | 0.396 | Maillard reaction inhibitor | 0.306 0.003 CID_154699826 | ||
| 0.474 | 0.083 | 0.567 | Apoptosis agonist | 0.567 0.056 CID_154699826 | CID_154699826 | |
| 0.389 | 0.005 | 0.389 | 5-Lipoxygenase inhibitor | 0.109 0.057 CID_154699826 | ||
| 0.34 | 0.002 | 0.34 | Peroxisome proliferator-activated receptor alpha antagonist | 0.073 0.006 CID_154699826 | ||
| 0.318 | 0.025 | 0.465 | Hepatoprotectant | 0.465 0.009 CID_154699826 | CID_154699826 | |
| 0.348 | 0.065 | 0.622 | Cholesterol antagonist | 0.622 0.016 CID_154699826 | CID_154699826 | |
| 0.302 | 0.02 | 0.302 | MAO inhibitor | |||
| 0.267 | 0.003 | 0.267 | Free fatty acid receptor 1 agonist | 0.102 0.004 CID_154699826 | ||
| 0.33 | 0.066 | 0.42 | Apoptosis antagonist | 0.42 0.033 CID_154699826 | CID_154699826 | |
| 0.273 | 0.015 | 0.273 | MAO B inhibitor | |||
| 0.222 | 0.03 | 0.232 | Interleukin 6 antagonist | 0.232 0.027 CID_154699826 | CID_154699826 | |
| 0.19 | 0.003 | 0.19 | Bcl-xL inhibitor | 0.133 0.004 CID_154699826 | ||
| 0.19 | 0.004 | 0.19 | Peroxisome proliferator-activated receptor alpha agonist | 0.108 0.01 CID_154699826 | ||
| 0.255 | 0.079 | 0.255 | Cardiotonic | 0.181 0.138 CID_154699826 | ||
| 0.17 | 0.025 | 0.17 | Bronchodilator | |||
| 0.141 | 0.004 | 0.141 | Estrogen-related receptor alpha antagonist | 0.072 0.009 CID_154699826 | ||
| 0.169 | 0.038 | 0.169 | Protein-tyrosine phosphatase 1B inhibitor | 0.162 0.041 CID_154699826 | ||
| 0.18 | 0.056 | 0.18 | Protein-tyrosine phosphatase inhibitor | 0.163 0.067 CID_154699826 | ||
| 0.125 | 0.002 | 0.125 | Thyroid hormone agonist | 0.032 0.011 CID_154699826 | ||
| 0.131 | 0.014 | 0.131 | Lipase inhibitor | 0.099 0.028 CID_154699826 | ||
| 0.164 | 0.048 | 0.164 | Neurotrophic factor | 0.143 0.065 CID_154699826 | ||
| 0.104 | 0.006 | 0.104 | Thromboxane synthase inhibitor | |||
| 0.103 | 0.005 | 0.103 | Peroxisome proliferator-activated receptor delta antagonist | 0.04 0.014 CID_154699826 | ||
| 0.139 | 0.051 | 0.139 | Cholesterol synthesis inhibitor | |||
| 0.229 | 0.143 | 0.506 | Transcription factor NF kappa B inhibitor | 0.506 0.043 CID_154699826 | CID_154699826 | |
| 0.132 | 0.055 | 0.259 | Monophenol monooxygenase inhibitor | 0.259 0.023 CID_154699826 | CID_154699826 | |
| 0.142 | 0.066 | 0.142 | Bone formation stimulant | 0.11 0.095 CID_154699826 | ||
| 0.113 | 0.041 | 0.113 | Estrogen receptor beta antagonist | |||
| 0.074 | 0.002 | 0.074 | Thyroid hormone beta agonist | |||
| 0.149 | 0.078 | 0.149 | Peroxidase inhibitor | |||
| 0.13 | 0.061 | 0.13 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.156 | 0.09 | 0.302 | Nitric oxide antagonist | 0.302 0.04 CID_154699826 | CID_154699826 | |
| 0.257 | 0.197 | 0.257 | Calcium channel L-type activator | |||
| 0.113 | 0.057 | 0.113 | Electron transport complex I inhibitor | |||
| 0.145 | 0.091 | 0.145 | Growth hormone agonist | |||
| 0.116 | 0.062 | 0.116 | Estrogen antagonist | |||
| 0.09 | 0.045 | 0.09 | Adrenaline agonist | |||
| 0.074 | 0.049 | 0.074 | Telomerase inhibitor | |||
| 0.064 | 0.042 | 0.077 | Nitric oxide donor | 0.077 0.025 CID_154699826 | CID_154699826 | |
| 0.039 | 0.018 | 0.039 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.106 | 0.093 | 0.106 | Cyclooxygenase 1 inhibitor | |||
| 0.045 | 0.032 | 0.045 | Beta adrenoreceptor agonist | |||
| 0.054 | 0.042 | 0.054 | Adenine nucleotide translocase inhibitor | |||
| 0.062 | 0.052 | 0.062 | Bcl2 antagonist | |||
| 0.049 | 0.041 | 0.074 | Glucose-6-phosphate translocase inhibitor | 0.074 0.014 CID_154699826 | CID_154699826 | |
| 0.113 | 0.107 | 0.113 | Vanilloid 1 agonist | |||
| 0.058 | 0.057 | 0.058 | Beta 2 adrenoreceptor agonist | |||
| 0.083 | 0.091 | 0.232 | Expectorant | 0.232 0.015 CID_154699826 | CID_154699826 | |
| 0.02 | 0.064 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.012 CID_154699826 | CID_154699826 | |
| 0.081 | 0.157 | 0.234 | Thrombolytic | 0.234 0.038 CID_154699826 | CID_154699826 | |
| 0.067 | 0.148 | 0.17 | AMP-activated protein kinase stimulant | 0.17 0.018 CID_154699826 | CID_154699826 | |
| 0.03 | 0.126 | 0.109 | Antineoplastic antibiotic | 0.109 0.042 CID_154699826 | CID_154699826 | |
| 0.009 | 0.11 | 0.038 | Sodium/glucose cotransporter 2 inhibitor | 0.038 0.009 CID_154699826 | CID_154699826 | |
| 0.105 | 0.211 | 0.221 | Platelet antagonist | 0.221 0.087 CID_154699826 | CID_154699826 | |
| 0.011 | 0.122 | 0.035 | Sodium/glucose cotransporter inhibitor | 0.035 0.008 CID_154699826 | CID_154699826 | |
| 0.072 | 0.209 | 0.14 | Protein kinase stimulant | 0.14 0.075 CID_154699826 | CID_154699826 | |
| 0.11 | 0.247 | 0.17 | Cyclic AMP phosphodiesterase inhibitor | 0.17 0.122 CID_154699826 | CID_154699826 | |
| 0.151 | 0.297 | 0.565 | Antibacterial | 0.565 0.025 CID_154699826 | CID_154699826 | |
| 0.074 | 0.261 | 0.288 | Platelet adhesion inhibitor | 0.288 0.038 CID_154699826 | CID_154699826 | |
| 0.091 | 0.384 | 0.123 | CC chemokine 6 receptor antagonist | 0.123 0.101 CID_154699826 | CID_154699826 | |
| 0.015 | 0.321 | 0.051 | Antibiotic Aminoglycoside-like | 0.051 0.013 CID_154699826 | CID_154699826 | |
| 0.021 | 0.337 | 0.088 | Topoisomerase I inhibitor | 0.088 0.081 CID_154699826 | CID_154699826 | |
| 0.037 | 0.41 | 0.316 | Immunostimulant | 0.316 0.074 CID_154699826 | CID_154699826 | |
| 0.033 | 0.417 | 0.396 | Angiogenesis stimulant | 0.396 0.022 CID_154699826 | CID_154699826 | |
| 0.011 | 0.442 | 0.061 | Protein 50S ribosomal subunit inhibitor | 0.061 0.03 CID_154699826 | CID_154699826 | |
| 0.033 | 0.527 | 0.2 | Tumour necrosis factor alpha release inhibitor | 0.2 0.109 CID_154699826 | CID_154699826 | |
| 0.043 | 0.542 | 0.281 | Immunosuppressant | 0.281 0.127 CID_154699826 | CID_154699826 | |
| 0.071 | 0.657 | 0.274 | Interleukin 2 agonist | 0.274 0.094 CID_154699826 | CID_154699826 | |
| 0.005 | 0.625 | 0.172 | Selectin antagonist | 0.172 0.015 CID_154699826 | CID_154699826 | |
| 0.018 | 0.657 | 0.114 | Cell wall synthesis inhibitor | 0.114 0.109 CID_154699826 | CID_154699826 | |
| 0.065 | 0.759 | 0.272 | Peptidyltransferase inhibitor | 0.272 0.037 CID_154699826 | CID_154699826 | |
| 0.017 | 0.731 | 0.216 | Antithrombotic | 0.216 0.159 CID_154699826 | CID_154699826 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |